Ball In Judge’s Court In Combination Product Classification Suit
This article was originally published in The Gray Sheet
Executive Summary
All the planned briefs have been filed in a case, Prevor v. United States Food and Drug Administration, that could have important implications for how FDA designates a product for either device or drug primary review.
You may also be interested in...
Califf Supports Changing Combo Product Pathway; FDA Developing Proposal
FDA concepts for a new pathway could be ready for congressional scrutiny within a year, commissioner nominee Robert Califf says during his confirmation hearing.
Califf Supports Changing Combo Product Pathway; FDA Developing Proposal
FDA concepts for a new pathway could be ready for congressional scrutiny within a year, commissioner nominee Robert Califf says during his confirmation hearing.
Califf Supports Combo Products Pathway At Confirmation Hearing
FDA's concepts for a new pathway could be ready for congressional scrutiny within a year, Deputy Commission Robert Califf said during his confirmation hearing before the Senate HELP Committee. Most committee members expressed support for Califf's nomination to lead FDA, although he fielded some questions on his ties to industry.